{"id":"tp-54942","type":"article-newspaper","title":"Amgen Announces Positive Phase 3 Results for Sjögren’s Drug","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/54942","datePublished":"2026-11-12T04:58:37.000Z","dateModified":"2026-11-12T04:58:37.000Z","language":"en","abstract":"The results came from the OASIZ-301 study of dazodalibep. Amgen plans to present the full findings at ACR Convergence 2026.","section":"Business","references":[]}